Early studies by Lyford-Pike et al. postulated an adaptive immune resistance created by the PD-1:PD-L1 interaction between CD8 + tumour-infiltrating lymphocytes and associated cancer cells in HNSCC [69]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.